Viewing Study NCT04480502


Ignite Creation Date: 2025-12-25 @ 3:55 AM
Ignite Modification Date: 2025-12-26 @ 2:45 AM
Study NCT ID: NCT04480502
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-17
First Post: 2020-07-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma
Sponsor: Tracon Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module